Vistagen Therapeutics (VTGN) Research & Development (2010 - 2026)
Vistagen Therapeutics' Research & Development was $6.55 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 58.8% from $15.92 million a year earlier and down 39.9% from the prior quarter.
Vistagen Therapeutics (VTGN) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Research & Development was $44.74 million through Sep 30, 2026, down 8.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $54.97 million, up 39.6% from FY2025.
- Research & Development shows a five-year compound annual growth rate of 35.7% (FY2021 to FY2026).
- In earlier fiscal years, Research & Development was $39.38 million in FY2025 (+96.7%), $20.02 million in FY2024 (-54.9%), $44.38 million in FY2023 (+25.3%) and $35.41 million in FY2022 (+196.9%).
- The fiscal Q2 2027 figure marks the lowest quarterly Research & Development since fiscal Q3 2024.
- Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 35.4%.
- The best year-over-year quarter for Research & Development over five years was fiscal Q1 2023 (growth of 180.2%); the worst was fiscal Q1 2024 (a decline of 72.6%).
- Per Business Quant data, VTGN's Research & Development in the three fiscal quarters before Q2 2027 was $10.91 million (Q1 2027), $13.06 million (Q4 2026) and $14.22 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 322,296.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 4.25 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 4.65 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 2.57 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 4.54 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | 6.55 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.55 Mn |
| Jun 30, 2026 | 10.91 Mn |
| Mar 31, 2026 | 13.06 Mn |
| Dec 31, 2025 | 14.22 Mn |
| Sep 30, 2025 | 15.92 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Mar 31, 2025 | 10.21 Mn |
| Dec 31, 2024 | 11.31 Mn |
| Sep 30, 2024 | 10.22 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 7.44 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 9.34 Mn |
| Dec 31, 2022 | 6.85 Mn |
| Sep 30, 2022 | 12.89 Mn |
| Jun 30, 2022 | 15.29 Mn |
| Mar 31, 2022 | 12.23 Mn |
| Dec 31, 2021 | 7.78 Mn |
Vistagen Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();